San Francisco Sentry Investment Group CA lessened its stake in shares of Waters Co. (NYSE:WAT) by 32.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,007 shares of the medical instruments supplier’s stock after selling 493 shares during the quarter. San Francisco Sentry Investment Group CA’s holdings in Waters were worth $196,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WAT. WP Advisors LLC bought a new stake in Waters during the 2nd quarter valued at approximately $101,000. Fort L.P. acquired a new position in Waters in the 2nd quarter valued at approximately $118,000. Cornerstone Advisors Inc. raised its holdings in Waters by 1,651.2% in the 2nd quarter. Cornerstone Advisors Inc. now owns 753 shares of the medical instruments supplier’s stock valued at $146,000 after acquiring an additional 710 shares in the last quarter. Checchi Capital Advisers LLC acquired a new position in Waters in the 3rd quarter valued at approximately $201,000. Finally, First Hawaiian Bank acquired a new position in Waters in the 3rd quarter valued at approximately $208,000. Institutional investors own 99.26% of the company’s stock.

Several research firms have commented on WAT. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating in a report on Thursday, August 23rd. Morgan Stanley dropped their target price on Waters from $205.00 to $204.00 and set an “equal weight” rating for the company in a report on Wednesday, July 25th. Robert W. Baird increased their target price on Waters from $201.00 to $212.00 and gave the stock an “outperform” rating in a report on Wednesday, July 25th. UBS Group began coverage on Waters in a report on Tuesday, October 9th. They issued a “neutral” rating and a $210.00 target price for the company. Finally, Cleveland Research raised Waters from a “sell” rating to a “neutral” rating in a report on Thursday, October 11th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $206.86.

In related news, Director Thomas P. Salice sold 3,500 shares of the stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $192.00, for a total transaction of $672,000.00. Following the sale, the director now directly owns 20,911 shares in the company, valued at approximately $4,014,912. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 8,000 shares of the stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $199.67, for a total value of $1,597,360.00. Following the sale, the director now owns 18,911 shares in the company, valued at $3,775,959.37. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,500 shares of company stock worth $3,031,840. 0.98% of the stock is owned by corporate insiders.

Shares of WAT opened at $196.08 on Wednesday. Waters Co. has a 1 year low of $167.93 and a 1 year high of $220.20. The company has a quick ratio of 5.93, a current ratio of 6.63 and a debt-to-equity ratio of 0.61. The company has a market capitalization of $14.98 billion, a PE ratio of 26.18, a P/E/G ratio of 2.37 and a beta of 0.94.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.90 by $0.02. The business had revenue of $578.02 million during the quarter, compared to analysts’ expectations of $587.43 million. Waters had a return on equity of 30.68% and a net margin of 2.32%. Waters’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.77 EPS. As a group, equities research analysts expect that Waters Co. will post 8.05 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/11/21/waters-co-wat-stake-lessened-by-san-francisco-sentry-investment-group-ca.html.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: Why is Cost of Capital Important?

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.